Search
for
Sort by
Research 781–810 of 1000+
- Lgr6+ stem cells and their progeny in mouse epidermis under regimens of exogenous skin carcinogenesis, and their absence in ensuing skin tumors
- Expression and Distribution of the Guanine Nucleotide-binding Protein Subunit Alpha-s in Mice Skin Tissues and Its Association with White and Black Coat Colors
- The murine hair follicle is a melatonin target
- Transcription factor FOXC1 positively regulates SFRP1 expression in androgenetic alopecia
- Improved forensic hair evidence for drugs of abuse by mass spectrometry
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- Real-World Ritlecitinib Treatment of Severe Alopecia Areata in the United States: Patient Characteristics and Physician Satisfaction According to a Secondary Database Analysis
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Time and depth resolved visualisation of the diffusion of a lipophilic dye into the hair follicle of fresh unfixed human scalp skin
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- HairSentinel: a time-aware anomaly detection framework for forecasting hairfall trends using temporal fusion transformers
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real‐world chart review in South Korea
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Degradation of human hair keratin scaffold material used to repair in-jured skeletal muscles of rabbits
- Two‐photon microscopy for intracutaneous imaging of stem cell activity in mice
- Scalp Analysis with Multiparametric Ultrasound before and after Application of Cosmetic with Vasoconstrictor Active
- 606 Connecting signaling dynamics with cell fates in live mice
- Imaging tumor angiogenesis with fluorescent proteins